| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
|
Nakagaki, Takehiro
|
|
|
17 |
4 |
p. 1850-1860
|
artikel
|
| 2 |
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
|
Nakagaki, Takehiro
|
|
|
17 |
4 |
p. 1850-1860
|
artikel
|
| 3 |
Advances in Therapeutic Approaches for Spontaneous Intracerebral Hemorrhage
|
Al-Kawaz, Mais N.
|
|
|
17 |
4 |
p. 1757-1767
|
artikel
|
| 4 |
Advances in Therapeutic Approaches for Spontaneous Intracerebral Hemorrhage
|
Al-Kawaz, Mais N.
|
|
|
17 |
4 |
p. 1757-1767
|
artikel
|
| 5 |
Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer’s Disease
|
Chen, Shuhua
|
|
|
17 |
4 |
p. 1813-1824
|
artikel
|
| 6 |
Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease
|
Chen, Shuhua
|
|
|
17 |
4 |
p. 1813-1824
|
artikel
|
| 7 |
Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned
|
Hung, Albert Y.
|
|
|
17 |
4 |
p. 1393-1405
|
artikel
|
| 8 |
Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
|
Hung, Albert Y.
|
|
|
17 |
4 |
p. 1393-1405
|
artikel
|
| 9 |
Approach to Cognitive Impairment in Parkinson’s Disease
|
Zhang, Qiang
|
|
|
17 |
4 |
p. 1495-1510
|
artikel
|
| 10 |
Approach to Cognitive Impairment in Parkinson's Disease
|
Zhang, Qiang
|
|
|
17 |
4 |
p. 1495-1510
|
artikel
|
| 11 |
Autonomic Dysfunction in Parkinson’s Disease
|
Pfeiffer, Ronald F.
|
|
|
17 |
4 |
p. 1464-1479
|
artikel
|
| 12 |
Autonomic Dysfunction in Parkinson's Disease
|
Pfeiffer, Ronald F.
|
|
|
17 |
4 |
p. 1464-1479
|
artikel
|
| 13 |
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease
|
Fischer, D. Luke
|
|
|
17 |
4 |
p. 1785-1795
|
artikel
|
| 14 |
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease
|
Fischer, D. Luke
|
|
|
17 |
4 |
p. 1785-1795
|
artikel
|
| 15 |
Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide
|
Pinto, Filipe
|
|
|
17 |
4 |
p. 2015-2027
|
artikel
|
| 16 |
Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide
|
Pinto, Filipe
|
|
|
17 |
4 |
p. 2015-2027
|
artikel
|
| 17 |
Cerebellar Astrocyte Transduction as Gene Therapy for Megalencephalic Leukoencephalopathy
|
Sánchez, Angela
|
|
|
17 |
4 |
p. 2041-2053
|
artikel
|
| 18 |
Cerebellar Astrocyte Transduction as Gene Therapy for Megalencephalic Leukoencephalopathy
|
Sánchez, Angela
|
|
|
17 |
4 |
p. 2041-2053
|
artikel
|
| 19 |
Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis
|
Deuel, Lisa M.
|
|
|
17 |
4 |
p. 1434-1455
|
artikel
|
| 20 |
Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis
|
Deuel, Lisa M.
|
|
|
17 |
4 |
p. 1434-1455
|
artikel
|
| 21 |
Correction to: Imaging Guidance for Therapeutic Delivery: the Dawn of Neuroenergetics
|
Alambyan, Vilakshan
|
|
|
17 |
4 |
p. 2090
|
artikel
|
| 22 |
Correction to: Imaging Guidance for Therapeutic Delivery: the Dawn of Neuroenergetics
|
Alambyan, Vilakshan
|
|
|
17 |
4 |
p. 2090
|
artikel
|
| 23 |
Correction to: Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis
|
Martínez-Palma, Laura
|
|
|
17 |
4 |
p. 2089
|
artikel
|
| 24 |
Correction to: Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis
|
Martínez-Palma, Laura
|
|
|
17 |
4 |
p. 2089
|
artikel
|
| 25 |
Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine
|
Lloyd, Joseph O.
|
|
|
17 |
4 |
p. 1973-1987
|
artikel
|
| 26 |
Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine
|
Lloyd, Joseph O.
|
|
|
17 |
4 |
p. 1973-1987
|
artikel
|
| 27 |
Current Management and Emerging Therapies in Multiple System Atrophy
|
Burns, Matthew R.
|
|
|
17 |
4 |
p. 1582-1602
|
artikel
|
| 28 |
Current Management and Emerging Therapies in Multiple System Atrophy
|
Burns, Matthew R.
|
|
|
17 |
4 |
p. 1582-1602
|
artikel
|
| 29 |
Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
|
Billnitzer, Andrew
|
|
|
17 |
4 |
p. 1681-1693
|
artikel
|
| 30 |
Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
|
Billnitzer, Andrew
|
|
|
17 |
4 |
p. 1681-1693
|
artikel
|
| 31 |
Current Perspectives on Aerobic Exercise in People with Parkinson’s Disease
|
Schootemeijer, Sabine
|
|
|
17 |
4 |
p. 1418-1433
|
artikel
|
| 32 |
Current Perspectives on Aerobic Exercise in People with Parkinson's Disease
|
Schootemeijer, Sabine
|
|
|
17 |
4 |
p. 1418-1433
|
artikel
|
| 33 |
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
|
Schneider, Susanne A.
|
|
|
17 |
4 |
p. 1378-1392
|
artikel
|
| 34 |
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
|
Schneider, Susanne A.
|
|
|
17 |
4 |
p. 1378-1392
|
artikel
|
| 35 |
Four-Repeat Tauopathies: Current Management and Future Treatments
|
VandeVrede, Lawren
|
|
|
17 |
4 |
p. 1563-1581
|
artikel
|
| 36 |
Four-Repeat Tauopathies: Current Management and Future Treatments
|
VandeVrede, Lawren
|
|
|
17 |
4 |
p. 1563-1581
|
artikel
|
| 37 |
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease
|
Tian, Ye
|
|
|
17 |
4 |
p. 1796-1812
|
artikel
|
| 38 |
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease
|
Tian, Ye
|
|
|
17 |
4 |
p. 1796-1812
|
artikel
|
| 39 |
Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
|
Buttery, Philip C.
|
|
|
17 |
4 |
p. 1539-1562
|
artikel
|
| 40 |
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
|
Buttery, Philip C.
|
|
|
17 |
4 |
p. 1539-1562
|
artikel
|
| 41 |
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy
|
Leo, Antonio
|
|
|
17 |
4 |
p. 2004-2014
|
artikel
|
| 42 |
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy
|
Leo, Antonio
|
|
|
17 |
4 |
p. 2004-2014
|
artikel
|
| 43 |
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
|
Artusi, Carlo Alberto
|
|
|
17 |
4 |
p. 1736-1746
|
artikel
|
| 44 |
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
|
Artusi, Carlo Alberto
|
|
|
17 |
4 |
p. 1736-1746
|
artikel
|
| 45 |
Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis
|
Eixarch, Herena
|
|
|
17 |
4 |
p. 1988-2003
|
artikel
|
| 46 |
Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis
|
Eixarch, Herena
|
|
|
17 |
4 |
p. 1988-2003
|
artikel
|
| 47 |
Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model
|
Espinosa, Alejandro
|
|
|
17 |
4 |
p. 1907-1918
|
artikel
|
| 48 |
Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model
|
Espinosa, Alejandro
|
|
|
17 |
4 |
p. 1907-1918
|
artikel
|
| 49 |
Management of psychiatric disorders in Parkinson’s disease
|
Weintraub, Daniel
|
|
|
17 |
4 |
p. 1511-1524
|
artikel
|
| 50 |
Management of psychiatric disorders in Parkinson's disease
|
Weintraub, Daniel
|
|
|
17 |
4 |
p. 1511-1524
|
artikel
|
| 51 |
Management of Tardive Syndrome: Medications and Surgical Treatments
|
Factor, Stewart A.
|
|
|
17 |
4 |
p. 1694-1712
|
artikel
|
| 52 |
Management of Tardive Syndrome: Medications and Surgical Treatments
|
Factor, Stewart A.
|
|
|
17 |
4 |
p. 1694-1712
|
artikel
|
| 53 |
Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
17 |
4 |
p. 1603-1621
|
artikel
|
| 54 |
Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
17 |
4 |
p. 1603-1621
|
artikel
|
| 55 |
Medical Management and Prevention of Motor Complications in Parkinson’s Disease
|
Aradi, Stephen D.
|
|
|
17 |
4 |
p. 1339-1365
|
artikel
|
| 56 |
Medical Management and Prevention of Motor Complications in Parkinson's Disease
|
Aradi, Stephen D.
|
|
|
17 |
4 |
p. 1339-1365
|
artikel
|
| 57 |
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models
|
Wu, Bin
|
|
|
17 |
4 |
p. 1878-1896
|
artikel
|
| 58 |
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models
|
Wu, Bin
|
|
|
17 |
4 |
p. 1878-1896
|
artikel
|
| 59 |
Modulation of the Microbiome in Parkinson’s Disease: Diet, Drug, Stool Transplant, and Beyond
|
Brown, Ethan G.
|
|
|
17 |
4 |
p. 1406-1417
|
artikel
|
| 60 |
Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond
|
Brown, Ethan G.
|
|
|
17 |
4 |
p. 1406-1417
|
artikel
|
| 61 |
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
|
Olson, Katherine E.
|
|
|
17 |
4 |
p. 1861-1877
|
artikel
|
| 62 |
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
|
Olson, Katherine E.
|
|
|
17 |
4 |
p. 1861-1877
|
artikel
|
| 63 |
Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice
|
Ishibashi, Daisuke
|
|
|
17 |
4 |
p. 1836-1849
|
artikel
|
| 64 |
Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice
|
Ishibashi, Daisuke
|
|
|
17 |
4 |
p. 1836-1849
|
artikel
|
| 65 |
Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention
|
Vaswani, Pavan A.
|
|
|
17 |
4 |
p. 1724-1735
|
artikel
|
| 66 |
Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention
|
Vaswani, Pavan A.
|
|
|
17 |
4 |
p. 1724-1735
|
artikel
|
| 67 |
Palliative Care for Parkinson’s Spectrum Disorders: an Emerging Approach
|
Katz, Maya
|
|
|
17 |
4 |
p. 1456-1463
|
artikel
|
| 68 |
Palliative Care for Parkinson's Spectrum Disorders: an Emerging Approach
|
Katz, Maya
|
|
|
17 |
4 |
p. 1456-1463
|
artikel
|
| 69 |
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease
|
Griñán-Ferré, Christian
|
|
|
17 |
4 |
p. 1825-1835
|
artikel
|
| 70 |
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
|
Griñán-Ferré, Christian
|
|
|
17 |
4 |
p. 1825-1835
|
artikel
|
| 71 |
Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD)
|
Sy, Michelle Ann C.
|
|
|
17 |
4 |
p. 1331-1338
|
artikel
|
| 72 |
Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD)
|
Sy, Michelle Ann C.
|
|
|
17 |
4 |
p. 1331-1338
|
artikel
|
| 73 |
Physiology-Based Treatment of Myoclonus
|
Pena, Ashley B.
|
|
|
17 |
4 |
p. 1665-1680
|
artikel
|
| 74 |
Physiology-Based Treatment of Myoclonus
|
Pena, Ashley B.
|
|
|
17 |
4 |
p. 1665-1680
|
artikel
|
| 75 |
Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats
|
Fang, Yuanjian
|
|
|
17 |
4 |
p. 1954-1972
|
artikel
|
| 76 |
Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats
|
Fang, Yuanjian
|
|
|
17 |
4 |
p. 1954-1972
|
artikel
|
| 77 |
Prelimbic Cortical Stimulation Improves Spatial Memory Through Distinct Patterns of Hippocampal Gene Expression in Aged Rats
|
Tan, Shawn Zheng Kai
|
|
|
17 |
4 |
p. 2054-2068
|
artikel
|
| 78 |
Prelimbic Cortical Stimulation Improves Spatial Memory Through Distinct Patterns of Hippocampal Gene Expression in Aged Rats
|
Tan, Shawn Zheng Kai
|
|
|
17 |
4 |
p. 2054-2068
|
artikel
|
| 79 |
Proactive Motor Functional Recovery Following Immersive Virtual Reality–Based Limb Mirroring Therapy in Patients with Subacute Stroke
|
Mekbib, Destaw B.
|
|
|
17 |
4 |
p. 1919-1930
|
artikel
|
| 80 |
Proactive Motor Functional Recovery Following Immersive Virtual Reality–Based Limb Mirroring Therapy in Patients with Subacute Stroke
|
Mekbib, Destaw B.
|
|
|
17 |
4 |
p. 1919-1930
|
artikel
|
| 81 |
Recombinant CCL17 Enhances Hematoma Resolution and Activation of CCR4/ERK/Nrf2/CD163 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Deng, Shuixiang
|
|
|
17 |
4 |
p. 1940-1953
|
artikel
|
| 82 |
Recombinant CCL17 Enhances Hematoma Resolution and Activation of CCR4/ERK/Nrf2/CD163 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Deng, Shuixiang
|
|
|
17 |
4 |
p. 1940-1953
|
artikel
|
| 83 |
Reperfusion plus Selective Intra-arterial Cooling (SI-AC) Improve Recovery in a Nonhuman Primate Model of Stroke
|
Wu, Di
|
|
|
17 |
4 |
p. 1931-1939
|
artikel
|
| 84 |
Reperfusion plus Selective Intra-arterial Cooling (SI-AC) Improve Recovery in a Nonhuman Primate Model of Stroke
|
Wu, Di
|
|
|
17 |
4 |
p. 1931-1939
|
artikel
|
| 85 |
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
17 |
4 |
p. 1897-1906
|
artikel
|
| 86 |
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
17 |
4 |
p. 1897-1906
|
artikel
|
| 87 |
Retraction Note to: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
17 |
4 |
p. 2091
|
artikel
|
| 88 |
Retraction Note to: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
17 |
4 |
p. 2091
|
artikel
|
| 89 |
Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics
|
Wang, Mei
|
|
|
17 |
4 |
p. 2028-2040
|
artikel
|
| 90 |
Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics
|
Wang, Mei
|
|
|
17 |
4 |
p. 2028-2040
|
artikel
|
| 91 |
Sleep Issues in Parkinson’s Disease and Their Management
|
Zuzuárregui, José Rafael P.
|
|
|
17 |
4 |
p. 1480-1494
|
artikel
|
| 92 |
Sleep Issues in Parkinson's Disease and Their Management
|
Zuzuárregui, José Rafael P.
|
|
|
17 |
4 |
p. 1480-1494
|
artikel
|
| 93 |
Surgical Treatment of Parkinson’s Disease: Devices and Lesion Approaches
|
Sharma, Vibhash D.
|
|
|
17 |
4 |
p. 1525-1538
|
artikel
|
| 94 |
Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches
|
Sharma, Vibhash D.
|
|
|
17 |
4 |
p. 1525-1538
|
artikel
|
| 95 |
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
|
Zhong, Michael
|
|
|
17 |
4 |
p. 1768-1784
|
artikel
|
| 96 |
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
|
Zhong, Michael
|
|
|
17 |
4 |
p. 1768-1784
|
artikel
|
| 97 |
Therapeutic Advances in Movement Disorders
|
Tanner, Caroline M.
|
|
|
17 |
4 |
p. 1325-1330
|
artikel
|
| 98 |
Therapeutic Advances in Movement Disorders
|
Tanner, Caroline M.
|
|
|
17 |
4 |
p. 1325-1330
|
artikel
|
| 99 |
Therapeutic Update on Huntington’s Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies
|
Dash, Deepa
|
|
|
17 |
4 |
p. 1645-1659
|
artikel
|
| 100 |
Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies
|
Dash, Deepa
|
|
|
17 |
4 |
p. 1645-1659
|
artikel
|
| 101 |
Therapy of Parkinson’s Disease Subtypes
|
Marras, Connie
|
|
|
17 |
4 |
p. 1366-1377
|
artikel
|
| 102 |
Therapy of Parkinson's Disease Subtypes
|
Marras, Connie
|
|
|
17 |
4 |
p. 1366-1377
|
artikel
|
| 103 |
The Regenerative Effect of Trans-spinal Magnetic Stimulation After Spinal Cord Injury: Mechanisms and Pathways Underlying the Effect
|
Chalfouh, C.
|
|
|
17 |
4 |
p. 2069-2088
|
artikel
|
| 104 |
The Regenerative Effect of Trans-spinal Magnetic Stimulation After Spinal Cord Injury: Mechanisms and Pathways Underlying the Effect
|
Chalfouh, C.
|
|
|
17 |
4 |
p. 2069-2088
|
artikel
|
| 105 |
Treating Post-traumatic Stress Disorder with Neuromodulation Therapies: Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation
|
Gouveia, Flavia Venetucci
|
|
|
17 |
4 |
p. 1747-1756
|
artikel
|
| 106 |
Treating Post-traumatic Stress Disorder with Neuromodulation Therapies: Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation
|
Gouveia, Flavia Venetucci
|
|
|
17 |
4 |
p. 1747-1756
|
artikel
|
| 107 |
Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders
|
Deputy, Stephen R.
|
|
|
17 |
4 |
p. 1713-1723
|
artikel
|
| 108 |
Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders
|
Deputy, Stephen R.
|
|
|
17 |
4 |
p. 1713-1723
|
artikel
|
| 109 |
Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation
|
Bledsoe, Ian O.
|
|
|
17 |
4 |
p. 1622-1644
|
artikel
|
| 110 |
Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation
|
Bledsoe, Ian O.
|
|
|
17 |
4 |
p. 1622-1644
|
artikel
|
| 111 |
Update on the Treatment of Ataxia: Medication and Emerging Therapies
|
Perlman, Susan L.
|
|
|
17 |
4 |
p. 1660-1664
|
artikel
|
| 112 |
Update on the Treatment of Ataxia: Medication and Emerging Therapies
|
Perlman, Susan L.
|
|
|
17 |
4 |
p. 1660-1664
|
artikel
|
Tijdschrift beschrijving